Novel fibroblast growth factors and methods of use thereof

Details for Australian Patent Application No. 2004238332 (hide)

Owner CuraGen Corporation

Inventors Sciore, Paul; Peterson, Jeffrey

Agent Cullen & Co

Pub. Number AU-A-2004238332

PCT Pub. Number WO2004/100892

Priority 60/469,353 09.05.03 US

Filing date 10 May 2004

Wipo publication date 25 November 2004

International Classifications

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/100892 Priority application(s): WO2004/100892

6 April 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Dec 2005

15 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238338-Catheter for uniform delivery of medication

2004238329-Cytotoxic indeno and isoindoloisoquinolones